Use of whole genome expression analysis in the toxicity screening of nanoparticles.
Bottom Line: The use of nanoparticles (NPs) offers exciting new options in technical and medical applications provided they do not cause adverse cellular effects.Application of lower particle doses and presence of protein decreased the total number of regulated genes but did not markedly influence the top regulated genes.Presence of protein mitigated cytotoxicity but did not cause a different pattern of regulated processes.
Affiliation: Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria. Electronic address: email@example.com.Show MeSH
Related in: MedlinePlus
Mentions: Exposure to 200 μg/ml PPS20 in DMEM + 10% FBS and to 200 μg/ml CPS20 particles in DMEM caused significant cytotoxicity after 24 h (Fig. 2a). After 4 h, 200 μg/ml PPS20 and 200 μg/ml CPS20 particles did not reduce viability significantly (data not shown). PPS20 particles suspended in DMEM without FBS reacted much more cytotoxic and 10 μg/ml PPS20 caused the same decrease in viability as 200 μg/ml PPS20 particles suspended in DMEM + 10% FBS. When CPS20 particles were assessed in DMEM + 1% FBS for 24 h, cytotoxicity was less pronounced than at the same concentration of CPS20 particles in DMEM without FBS; instead of 5 ± 0.5% viability at 200 μg/ml CPS20 particles after exposure to DMEM without FBS, viability was 68 ± 9% (data not shown). At 10% FBS in the medium no cytotoxicity was observed up to 1 mg/ml CPS20 particles (data not shown). 50 μg/ml SCNTc, being the most cytotoxic of the CNTs tested, caused no significant decrease in viability (Fig. 2b). To verify absence of cytotoxicity in the microarray experiments viability testing was performed in parallel (data not shown).
Affiliation: Center for Medical Research, Medical University of Graz, Stiftingtalstr. 24, 8010 Graz, Austria. Electronic address: firstname.lastname@example.org.